Device Trial Radar · NCT04709068
Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization
Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
8
Actual
Start
Feb 8, 2021
Primary completion
May 3, 2021
Study completion Jun 1, 2021
Sponsor
- Lead sponsor
- Current HealthNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Biomedical Advanced Research and Development Authority
- First posted
- Jan 14, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to remotely monitor individuals who have tested positive for COVID-19 to learn more about progression and recovery from the disease. Individuals who test positive for COVID-19 will wear the Current Health wearable device continuously and answer a brief series of questions on Current Health tablet daily for up to 30 days. The health data will be used to develop predictive models of hospitalization risk.
Conditions
- Covid19
Interventions
Current HealthDevice
wearable device and tablet used to collect health measures at home
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participant ComplianceTime frame: up to 30 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Current Health
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.